Literature DB >> 31468129

Xylitol treats nasal mucosa in rhinitis medicamentosa: an experimental rat model study.

Behram Cam1, Murat Sari2, Ahmet Midi3, Ozgül Gergin4.   

Abstract

OBJECTIVE: Rhinitis medicamentosa is drug-induced rhinitis which occurs by prolonged and overdose usage of topical nasal decongestants. There is not much of treatment choice rather than nasal steroids. In this pathological study, we have been aimed to represent the healing effects of xylitol on damaged nasal mucosa due to rhinitis medicamentosa.
METHOD: 30 Wistar rats were separated into 5 groups. During 2 months, oxymetazoline was given to the first group, and saline was given to second group intranasally. First and second group animals were examined at the end of 2 months and rhinitis medicamentosa was detected. Oxymetazoline was given to the third, fourth, and fifth groups during 2 months. Then xylitol solution, mometasone, and saline were applied, respectively, for 15 days. After the experiment, rats' nasal mucosas were evaluated histopathologically.
RESULTS: Xylitol and mometasone were found to be more effective than the control group in terms of histopathological changes. Effectivity of xylitol and mometasone was compared and not a significant value was determined.
CONCLUSIONS: According to the results, xylitol solution is effective as mometasone, usable and well-priced in the treatment of rhinitis medicamentosa. More comprehensive and ultrastructural studies on animals and human studies with rhinometric evaluation should be performed.

Entities:  

Keywords:  Mometasone; Nasal decongestants; Nasal mucosa; Rhinitis medicamentosa; Xylitol

Mesh:

Substances:

Year:  2019        PMID: 31468129     DOI: 10.1007/s00405-019-05605-3

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing.

Authors:  J Zabner; M P Seiler; J L Launspach; P H Karp; W R Kearney; D C Look; J J Smith; M J Welsh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Rhinitis medicamentosa: what an otolaryngologist needs to know.

Authors:  Jayesh Doshi
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-12-19       Impact factor: 2.503

Review 3.  Drug-induced rhinitis.

Authors:  M Varghese; M C Glaum; R F Lockey
Journal:  Clin Exp Allergy       Date:  2010-03       Impact factor: 5.018

Review 4.  Rhinitis medicamentosa.

Authors:  J T Ramey; E Bailen; R F Lockey
Journal:  J Investig Allergol Clin Immunol       Date:  2006       Impact factor: 4.333

5.  Management of Rhinitis Medicamentosa: A Systematic Review.

Authors:  Shana M Zucker; Blair M Barton; Edward D McCoul
Journal:  Otolaryngol Head Neck Surg       Date:  2018-10-16       Impact factor: 3.497

6.  Xylitol enhances bacterial killing in the rabbit maxillary sinus.

Authors:  Christopher L Brown; Scott M Graham; Benjamin B Cable; Egon A Ozer; Peter J Taft; Joseph Zabner
Journal:  Laryngoscope       Date:  2004-11       Impact factor: 3.325

7.  Turku sugar studies. V. Final report on the effect of sucrose, fructose and xylitol diets on the caries incidence in man.

Authors:  A Scheinin; K K Mäkinen; K Ylitalo
Journal:  Acta Odontol Scand       Date:  1976       Impact factor: 2.331

8.  Sugar alcohols, caries incidence, and remineralization of caries lesions: a literature review.

Authors:  Kauko K Mäkinen
Journal:  Int J Dent       Date:  2010-01-05

9.  Mucosal changes in rhinitis medicamentosa.

Authors:  Chun-Yu Lin; Po-Hsu Cheng; Sheen-Yie Fang
Journal:  Ann Otol Rhinol Laryngol       Date:  2004-02       Impact factor: 1.547

10.  Determination of oxidative stress and effect of erdosteine on rhinitis medicamentosa in a rat model.

Authors:  Recep Dokuyucu; Cengiz Cevik; Gul Soylu Ozler; Tumay Ozgur; Cengiz Arli; Fatih Sefil; Zafer Yonden
Journal:  Eur J Pharmacol       Date:  2014-09-18       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.